Cancer News and Research

Latest Cancer News and Research

Researchers develop breakthrough technique for genomic analysis of long DNA molecules

Researchers from McGill University and the G-nome Qu-bec Innovation Centre have achieved a technical breakthrough that should result in speedier diagnosis of cancer and various pre-natal conditions.

5 Aug 2014

New calculator helps men assess risk of prostate cancer

A calculator to help men and their doctors assess their risk of prostate cancer, developed at the UT Health Science Center, has had a major upgrade to enhance how men and their physicians better understand a man's risk of prostate cancer.

5 Aug 2014

Researchers to track fate in body of materials used in breakthrough medicines

The University of Liverpool has been awarded -2 million to become a leading centre in the UK for tracking the fate in the body of materials used in breakthrough medicines.

5 Aug 2014

Hepatitis C could become a rare disease by 2036

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the simulation are reported in the August 5 edition of the journal Annals of Internal Medicine.

5 Aug 2014

Researchers postulate similarities between changes in cells and origins of triple negative breast cancer

Healthy breast cells may be able to reinvent themselves -- some have the flexibility to change after they are mature -- which leads researchers to postulate that similarities exist between this occurrence and the origins of a particularly aggressive type of breast cancer.

5 Aug 2014

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.

5 Aug 2014

Repurposed drug used to treat ovarian cancer gives positive results

A repurposed drug originally used to treat ovarian cancer saw positive results for patients with advanced peritoneal cancers during a phase I clinical trial at The University of Kansas Cancer Center.

5 Aug 2014

Viewpoints: Ignagni on prices of new drugs; Sen. Johnson on the difficulty of suing a president

Lately, there has been considerable debate about the soaring prices of specialty drugs, which are aimed at difficult-to-treat diseases.

5 Aug 2014

Findings support regular mammography screening in women ages 75 and older

Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases, according to a new study published online in the journal Radiology.

5 Aug 2014

Researchers receive $435K to study how environmental factors affect genes that cause autism

Over the last decade, autism research has been primarily focused on finding genes that may "cause" autism. However, little information exists on gene-environment interactions that may increase risk for autism.

5 Aug 2014

Scientists spearhead new £6 million initiative to find better ways to prevent cancer

Queen's University scientists are helping to spearhead a new £6 million initiative to find better ways to prevent cancer.

5 Aug 2014

Triple therapy for glioblastoma has prolonged survival of mice with brain cancers

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report by scientists at the Johns Hopkins Kimmel Cancer Center.

5 Aug 2014

Researchers study effect of alcohol on neural activity using fruit flies

Seeking eventual solutions to problems ranging from alcoholism, cancer and Alzheimer's to finding better ways to clean contact lenses and use Lego models to build bridges, University of Houston (UH) students devoted the summer to some serious scholarship.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

When Michael and Sandra Friedlander first came to the Virginia-Maryland College of Veterinary Medicine three years ago with their dog, Grayton, they learned some bad news: Grayton had nasal adenocarcinoma, a form of cancer with a short life expectancy.

5 Aug 2014

St. Joseph Hoag Health, CHOC Children's to jointly form accountable care organization

St. Joseph Hoag Health and CHOC Children's announced this morning that they will form an accountable care organization (ACO), bringing together outstanding health care providers throughout Orange County.

4 Aug 2014

Updated guidelines for prostate cancer survivorship care published in Journal of Men's Health

Many of the more than 2.5 million men in the U.S. who have received treatment for prostate cancer deal with the often disabling side effects of surgery and radiation and hormonal therapies.

4 Aug 2014

5-LO enzyme plays important role in the survival of leukaemic AML stem cells

Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.

4 Aug 2014

Health insurer to stop covering uterine procedure

Highmark Inc., which sells plans in Pennsylvania, Delaware and West Virginia, will stop covering power morcellation, a technique often used in hysterectomies, after the Food and Drug Administration advised doctors against it because it may spread cancer.

4 Aug 2014

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).

4 Aug 2014

Cancer News and Research

Latest Cancer News and Research

Researchers develop breakthrough technique for genomic analysis of long DNA molecules

New calculator helps men assess risk of prostate cancer

Researchers to track fate in body of materials used in breakthrough medicines

Hepatitis C could become a rare disease by 2036

Researchers postulate similarities between changes in cells and origins of triple negative breast cancer

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

Repurposed drug used to treat ovarian cancer gives positive results

Viewpoints: Ignagni on prices of new drugs; Sen. Johnson on the difficulty of suing a president

Findings support regular mammography screening in women ages 75 and older

Researchers receive $435K to study how environmental factors affect genes that cause autism

Scientists spearhead new £6 million initiative to find better ways to prevent cancer

Triple therapy for glioblastoma has prolonged survival of mice with brain cancers

Researchers study effect of alcohol on neural activity using fruit flies

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

St. Joseph Hoag Health, CHOC Children's to jointly form accountable care organization

Updated guidelines for prostate cancer survivorship care published in Journal of Men's Health

5-LO enzyme plays important role in the survival of leukaemic AML stem cells

Health insurer to stop covering uterine procedure

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in